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Abstract
Background: To investigate the diagnostic reliability of selective microdochectomy after direct
ductoscopic wire marking of suspect lesions in patients with pathological nipple discharge.
Methods: Selective microdochectomy due to pathological discharge was performed in 33 patients
with mean age of 51.7 years. Ductoscopes of 0.9 and 1.1 mm in diameter with a channel for wire
marking were used. Only patients without sonographic or mammographic correlation for the
discharge were included. The pathologic mammary duct was wire marked and extirpated under
direct visual guidance via the ductoscope. The histological results were compared with cytology,
galactography and ductoscopy.
Results: In 24 out of 33 cases (72%) an intraductal, epithelial proliferation was found histologically.
The following sensitivities for intraductal, epithelial proliferations could be determined: cytology
4%, galactography 74%, and ductoscopy 78%.
Conclusion: The method allows selective microdochectomy of the pathological duct and the
intraductal proliferation under visual guidance. The resection volume can be reduced in contrast
to the unselective ductectomy after injection of methylene blue.
Background
Pathological nipple discharge is the only symptom which
cannot yet be histologically clarified by minimal invasive
procedures such as core needle biopsy or vacuum assisted
biopsy in clinical routine. It is define as spontaneous, per-
sistent, unilateral and coming from a single duct during
non-lactational period [1]. The imaging techniques mam-
mography and galactography [2,3] as well as sonography
and magnetic resonance imaging (MRI) cannot replace
histological examination in patients with pathologic nip-
ple discharge (Fig. 1). Controversy exists in the diagnostic
value of nipple discharge cytology [4-6]. In 10 to 15% of
the cases, pathological discharge is the only symptom of
breastcancer [7-10]. Techniques like major duct excision
and microdochectomy are used for histological clarifica-
tion [1,11-13]. Here, a coloured liquid dye (methylene
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blue) is instilled into the affected lactiferous duct, making
the duct visible to the surgeon. Finally, the coloured duct
is dissected through an infraareolar incision and excised
with the surrounding tissue in a cone shape. Since lactifer-
ous ducts divide into bifurcations, it is understandable
that this procedure might be nonselective. This is because
the instilled dye may disperse into a duct system which is
not responsible for the discharge. Ductoscopy has the
advantage of direct visualisation of the intraductal lesion
[14-21].
The aim of this prospective study was to investigate the
diagnostic reliability of selective microdochectomy after
direct ductoscopic wire marking of pathologic lesions in
patients with pathological nipple discharge and to clarify
whether the method represents an alternative to standard
procedure using methylene blue dye.
Methods
Patients
33 consecutive women who presented with pathologic
nipple discharge between April 2007 and September 2008
were included in this prospective study. The study was
conducted under the guidelines of the local ethics com-
mittee, and in accordance with the principles of the Dec-
laration of Helsinki. The mean age of the patients was
51.7 years (range 20 – 71 years). The inclusion criteria
were: pathologic nipple discharge due to breast pathology
coming from only one lactiferous duct, imaging without
abnormal findings that could be biopsied and consent of
the patients to take part in the study. No patient had to be
excluded from the study and all underwent complete
workup with nipple smear, mammography, sonography,
and galactography.
A selective microdochectomy was performed after ductos-
copic wire marking. An origin for the discharge outside
the breast was excluded in all women, and we proceeded
according to the algorithm shown in Fig. 1. Women were
only included in the study if the discharge appeared uni-
laterally from only one lactiferous duct. A cytological nip-
ple smear was taken from 32 women. One patient
declined the nipple smear. Alongside the clinical exami-
nation, all women received a mammography (Senogra-
phe 2000D, GE, Fairfield) galactography (Ultravist 300,
Schering, Berlin) as well as breast ultrasound examination
(IU 22, 12 MHz, Philips, Hamburg). Mammography and
sonography were classified according to BI-RADS®. The BI-
RADS® classification (breast imaging reporting and data
system) of the ACR (American College of Radiology) pro-
vides a standardised classification of imaging findings
according to the likelihood of malignancy. Patients who
had a mammographic or sonographic origin for the dis-
charge as well as a palpable lesion were excluded from the
study and biopsied using a minimal invasive technique.
The study was perfomed in cooperation with the Working
Group for Minimal Invasive Breast Interventions of the
German Senology Society.
Microdochectomy/Ductoscopy
All procedures were performed under general anaesthesia.
The mean duration of the procedure was 32 minutes
(Range: 30–50 minutes). After preoperative marking of
Diagnostic algorithm for pathological nipple discharge Figure 1
Diagnostic algorithm for pathological nipple discharge.BMC Cancer 2009, 9:151 http://www.biomedcentral.com/1471-2407/9/151
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the planned infraareolar incision, the discharging lactifer-
ous duct was dilated using Hegar's dilators to 1.2 mm.
Finally, the ductoscope (Karl Storz, Tuttlingen, 1.1 mm
diameter with working channel, 0.9 mm without working
channel, semiflexible) was introduced into the duct (Fig.
2). The ductoscope possesses two working channels.
Channel 1 allows the continuous supply of sodium chlo-
ride 0.9% solution for dilatation of the mammary ducts.
Channel 2 allows insertion of the wire marker. An endo-
camera and conventional monitor screen were used for
image visualisation. The lesions were documented photo-
graphically. After passage of the proximal section of the
milk duct (Fig. 3) and arrival at the first bifurcation
(Pignose sign) (Fig. 4), the surgeon is challenged with
which milk duct is to be further examined. In most cases,
this can be solved with the so-called „jet-stream" sign, a
backflow of the pathological secretion, which can be trig-
gered by pressure on the dorsal section of the breast. The
backflow of the pathological discharge indicates the cor-
rect duct to follow. If this was not possible, all following
mammary ducts were explored, as far as technically possi-
ble. The detected lesion was finally marked with a wire
(Somatex, Teltow) through the working channel (Fig. 5).
A reliable correlation between image and histology is
therefore comprehensible. When the wire marker was
positioned, the ductoscope was removed from the breast.
Surgical microdochectomy followed using hydrodissec-
Insertion of the ductoscope Figure 2
Insertion of the ductoscope.
Normal lactiferous duct Figure 3
Normal lactiferous duct.
Pignose sign (bifurcation) Figure 4
Pignose sign (bifurcation).BMC Cancer 2009, 9:151 http://www.biomedcentral.com/1471-2407/9/151
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tion, after subcutaneous injection of 20–30 ml prilocaine
1% with epinephrine 1:200000. After the wire-marked
milk duct was dissected, it was suture marked retroareo-
larly for orientation (Fig. 6). Haemostasis and glandular
adaptation with wound closure finally followed in the
usual manner.
Patients received a thoracic compression bandage for 24
hours and were asked to return for follow-up one week
postoperatively.
Results
Ductoscopy
The ductoscope could be introduced into the correct lac-
tiferous duct in all 33 cases. A mean of 4 lactiferous ducts
were ductoscopically examined during each procedure
(range 1–12). Bloody discharge was present in 29 cases,
and a serous discharge in 4 cases. Flat intraductal red
deposits were diagnosed ductoscopically in 6 cases, poly-
poid structures in 18 cases, and in 9 cases no abnormality
was found (including 3 cases of false passage). In the case
of a false passage, surgery was performed via a retroareolar
cone extirpation according to Urban. In one case, the false
passage already arose during galactography and the perfo-
ration site could be detected ductoscopically. In all 3 cases
of false passage, a papilloma was detected histologically.
The detected intraductal lesions or the proximal section of
the pathological lactiferous ducts could be ductoscopi-
cally marked in all cases.
In order to gain a representative tissue sample, at least a
further 2 cm of the duct, distally to the suspect lesion seen
via ductoscopy, was also included in the resection.
We realized a learning curve of about 20 procedures.
Galactography
32 galactographies were performed. One patient declined
the procedure. Infiltration of the milk duct with contrast
media was inadequate in 5 cases. An intraductal mass was
diagnosed galactographically in 20 cases, while in 7 cases
the lactiferous ducts were galactographically unsuspi-
cious.
Histology and Cytology
Twenty-two papillomas, 1 invasive ductal carcinoma with
intraductal component (DCIS), 1 DCIS, 1 galactophoritis,
1 lymphocytic lobulitis as well as 7 other benign results
were diagnosed histologically.
The cytological smears were negative (foamy macro-
phages, rare single cells, clear background secretion) in 29
cases, papillomatous cells were diagnosed in 2 cases and
in 2 cases an analysis was not possible. In the 2 cases
where cytology revealed papillomatous cells, this result
correlated in one case with the histology, and in the sec-
ond case, a lymphocytic lobulitis was found.
Table 1 shows the results of galactography, ductoscopy
and cytology compared to histological results. The highest
detection rate could be determined by ductoscopy, fol-
lowed by galactography.
Wire marking of the intraductal papilloma Figure 5
Wire marking of the intraductal papilloma.
Selective lactiferous duct sample Figure 6
Selective lactiferous duct sample.BMC Cancer 2009, 9:151 http://www.biomedcentral.com/1471-2407/9/151
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Complications
Medical complications such as haematomas requiring
revision and secondary bleeding, inflammation requiring
antibiotics or objectionable cosmetic results did not
occur. In one case where the lactiferous duct had to be dis-
sected very close to the areola, there was a temporary
reduction in blood perfusion with partial necrosis. This
healed well with conservative treatment.
In 2 cases, there was breakage of the fibreoptic fibres in the
ductoscope, and the procedure had to be continued with
a replacement ductoscope. We believe that the ductoscope
broke because the surgeon tried to enter a milk duct which
was at too steep an angle. The flexibility of the used duc-
toscopes are limited.
Follow up
The patients were examined one week postoperatively.
Patients with benign findings were advised to attend for a
clinical examination including mammography and
sonography after 6 months.
No conclusion can be made about recurrence due to the
short follow-up period.
Discussion
The clarification of pathological nipple discharge is still a
particular diagnostic challenge [9]. On the one hand, this
is because the imaging techniques such as mammography
and sonography do not have a high diagnostic value when
it comes to pathologic nipple discharge; on the other
hand, this symptom cannot yet be histologically con-
firmed with minimal invasive techniques.
In this study intraductal epithelial proliferation could be
histologically detected in 73% (24/33) of cases. In all of
these 24 cases, the lesions could not be diagnosed either
by clinical examination, sonography or mammography.
Galactography successfully demonstrated an intraductal
lesion that could be successfully confirmed histologically
in 73% (17/23) of the cases. In 33% (3/9 cases) a false
positive galactography occured (histological confirmation
could not be made on the postoperative specimen). We
recommended a 6 month follow up for these patients
(sonography).
Ductoskopy successfully demonstrated an intraductal
lesion that could be histologically confirmed in 78% (18/
23). Two false negative results occured from ductocopy. In
both cases papillomas could be histologically diagnosed.
The invasive ductal carcinomas with intraductal compo-
nent as well as the DCIS were both detected by ductoscopy
(Table 1).
In those 3 cases of galactography that were false positive
the ductoscopy showed a flat intraductal lesion in 1 case
and no intraductal lesion in 2 cases. In those 5 cases of
false positive ductoscopy the galactography showed an
Table 1: Detection rate of ductoscopy, galactography and cytology in comparison to histological results (n = 32, galactography was 
refused in one case)
Intraductal, epithelial proliferations N = 23 No intraductal proliferations N = 9
Ductoscopy
positive 18 (78%) 5 (56%)
negative 2 (9%) 4 (44%)
False passage 3 (13%) 0
Galactography
positive 17 (74%) 3(33%)
negative 2 (9%) 5 (56%)
not analysable 4 (17%) 1 (11%)
Cytology
positive 1 (4%) 1 (11%)
negative 20 (87%) 8 (89%)
not analysable 2 (9%) 0BMC Cancer 2009, 9:151 http://www.biomedcentral.com/1471-2407/9/151
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intraductal mass in 1 case and in 4 cases an unsuspicious
lactiferous duct.
False passage occurred in three cases. This negatively influ-
enced the interpretation of the study because of the small
number of cases. It should be pointed out that one false
passage already occurred during the galactography and
the other two occurred very early in the study. We inter-
pret this as being a result of our steep learning curve.
The challenge in the clarification of patients with patho-
logical nipple discharge in one collective, as described in
this study, (i.e. without imaging correlation from mam-
mography or sonography) is the histological confirma-
tion. [14]. Open biopsy according to microdochectomy
[1,11,12], i.e. after instillation of methylene blue dye into
the pathological duct only allows an indirect view of the
lactiferous ducts from the exterior. In combination with
galactography [2,3,22-26] it is possible for the surgeon to
identify the blue coloured lactiferous duct system and
excise them. With this technique however, microdochec-
tomy follows without direct visualisation of the lesion.
This means that the resection volume must be relatively
large and that the surgeon has no intraoperative control as
to whether the intraductal proliferation, if present at all,
was removed or not. If the pathologist reports an incon-
spicuous lactiferous duct, the question of the pathogene-
sis of the pathological discharge remains unknown. Four
differential diagnostic possibilities can be causative here:
1) extirpation of the wrong lactiferous duct, 2) the biopsy
was too superficial, i.e., the lesion lies more distal, 3) loss
of the lesion during the pathological work up, 4) no intra-
ductal proliferation which is responsible for the patholog-
ical discharge exists.
The follow-up in this particular situation is difficult. As a
result of dissection of the lactiferous duct, the symptom of
bloody discharge should no longer occur, assuming the
correct duct has been removed. Clinical examination,
sonography and mammography, along with MRI for spe-
cific questions, remain the only follow-up investigations.
After non-representative ductectomy, intraductal lesions
might be recognised sonographically inside a duct ectasia
caused by a discharge blockage. However, a control mam-
mography should be performed in these patients, even
though the interpretation of the images can be hindered
by postoperative scars.
Here the advantage of direct ductoscopic visualisation of
the lesion to be removed is evident. Both the surgeon and
pathologist gain information as a result of ductoscopic
detection and marking of the suspect lesion. The patholo-
gist can also be informed about the depth of the site.
Whether microdochectomy still has to be performed
when a lesion has not been detected ductoscopically can-
not be answered with the current data. False negative
biopsies can also occur under ductoscopic visualisation.
One reason for this could be a non-representative ductec-
tomy after dilating a false lactiferous duct. Another reason
for false negative biopsies is that the presence of further
lesions distal to a discovered intraductal lesion cannot be
excluded. This is why the galactography result showing
the complete length of the lactiferous duct is important
information for the surgeon.
A further advantage of ductoscopic marking is the reduc-
tion in the resection volume compared to standard proce-
dure with methylene blue dye. According to our
experience, the resection volume under ductoscopic visu-
alisation was subjectively smaller than that of the conven-
tional ductectomy after methylene blue instillation. An
objective study of these parameters has, nevertheless, not
been carried out in the available studies.
It also should be mentioned that the abdication of meth-
ylene blue dye using ductoscopy might be meaningful.
Cases have been described in the literature of tissue necro-
sis after application of methylene blue dye[27,28] which
has been associated with a number of local complications
due to its tissue reactive properties. Some authors have
therefore suggested replacing methylene blue with an
alternative dye.
Considering the future prospects of technical equipment
development, it would be desirable to develop a ductos-
copic minimal invasive method for clarification of patho-
logical breast discharge. The first experiences of minimal
invasive clarification of intraductal lesions solely with the
ductoscope have been described in the literature [29-31].
Innovative approaches such as ductoscopic-vacuum
assisted biopsy removal of intraductal lesions avoiding
open biopsy or instruments using the working channel of
the ductoscope for cytological or histological samples [32]
are already technically realisable today. Similarly, it is also
conceivable to biopsy a ductoscopically discovered lesion
with classical vacuum assisted breast biopsy under com-
bined sonographic-ductoscopic control. However, these
procedures are still in the experimental stages.
Conclusion
Microdochectomy after ductoscopic wire marking allows
specific histological clarification of intraductal lesions
under direct visualisation in the case of pathological nip-
ple discharge. A reduction in the resection volume com-
pared to the standard ductectomy after methylene blue
dye administration appears to be possible with this tech-
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